The 3rd International Electronic Conference on Cancers: New Targets for Cancer Therapies (IECC 2023)

Dear colleagues,

We are pleased to announce the 3rd International Electronic Conference on Cancers: New Targets for Cancer Therapies (IECC 2023), which will be held from 16–30 March 2023.

The opportunities for new therapeutic targets have expanded tremendously. In recent years, cancer genomics has expanded our view of cancer vulnerabilities, new technologies have changed the paradigm of what can be successfully targeted, and new immunotherapy targets are emerging rapidly. This conference aims to promote and advance the coordinated progress in oncology research to foster the development of innovative therapeutic strategies. It will bring together experts in basic, translational, and clinical research to discuss the current research and the opportunities as well as obstacles that lie ahead in the field.

The focus of this conference is the translation of recent discoveries into new therapeutic targets for cancer therapies. Topics of interest include, but are not limited to, the following:

• Translational cancer genomics and epigenomics.
• Emerging immunotherapy targets.
• Overcoming therapeutic hurdles in resistance and undruggable proteins.

There will be five specific sessions:

Session 1: Genome-wide Approaches for Target Identification.
Session 2: Targeting Metastasis.
Session 3: Novel Immunotherapy Targets.
Session 4: Novel Approaches for ‘Undruggable’ Targets.
Session 5: Overcoming Therapeutic Resistance.

Participants will have the opportunity to examine, explore, and critically engage with issues and advances in these areas. We hope to facilitate discussions and exchange within the community.

This event will solely be an online proceeding, which allows for participation from all over the world with no concerns of travel and related expenditures. This type of conference is particularly appropriate and useful because research concerned with cancers is progressing rapidly. An electronic conference provides a platform for rapid and direct exchanges about the latest research findings and novel ideas. Participation in, as well as the “attendance” of, this online conference is free of charge.

This electronic conference is sponsored by MDPI and the scientific journal Cancers. The accepted conference proceedings papers and presentations will be available online for discussion during 16–30 March 2023 and will be published in the journal Medical Sciences Forum. All participants are cordially encouraged to submit an extended full manuscript to the Cancers conference Special Issue "IECC2023: New Targets for Cancer Therapies" with a 20% discount on the APC. Cancers (ISSN 2072-6694; IF 6.575) is a peer-reviewed and open access journal of oncology that is published semimonthly online by MDPI.

The best paper will receive an award of CHF 500, and the best presentation (poster, slides, or video) will receive an award of CHF 300. Both will also receive an offer to publish an extended paper, with a 20% discount, in a Special Issue "IECC2023: New Targets for Cancer Therapies" of the journal Cancers.

We hope that the community will share this enthusiasm and help make this conference a success.

Kind regards,
Dr. Carlos S. Moreno
The Chair of the 3rd International Electronic Conference on Cancers: New Targets for Cancer Therapies

Follow the conference organizer on Social Media